Compares intranasal corticosteroids and antihistamines for quality of life in pediatrics, indicating varying efficacy by age group.
Summary Daily intranasal corticosteroids improved quality of life most in adolescents (12–18 years) with seasonal allergic rhinoconjunctivitis. Antihistamines showed greater quality‐of‐life improvement than intranasal corticosteroids in children (6–11 years).
No takes yet. Share an insight, caveat, or question.
Tameeris et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: